Markets:

Overview

News

Currencies

International

Treasuries

Jazz Pharmaceuticals plc - Ordinary Shares (NQ:JAZZ)

256.08 -0.84 (-0.33%)

Streaming Delayed Price Updated: 12:49 PM EDT, Jul 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Jazz Pharmaceuticals plc - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

FDA-Approved Cannabis-Based Drug Shows Promising Results As A Treatment For War Veterans: Study Finds Improvement In Cognitive, Mood, Pain-Related Symptoms ↗

September 19, 2024

Veterans: Epidiolex shows promise in treating Gulf War Illness, offering hope for those affected. Learn how it might benefit them.

Via Benzinga

Despite its impressive fundamentals, NASDAQ:JAZZ remains undervalued. ↗

September 19, 2024

JAZZ PHARMACEUTICALS PLC (NASDAQ:JAZZ) is an undervalued gem with solid fundamentals.

Via Chartmill

A Closer Look at 12 Analyst Recommendations For Jazz Pharmaceuticals ↗

September 09, 2024

Via Benzinga

When you look at NASDAQ:JAZZ, it's hard to ignore the strong fundamentals, especially considering its likely undervaluation. ↗

August 29, 2024

JAZZ PHARMACEUTICALS PLC (NASDAQ:JAZZ) is an undervalued gem with solid fundamentals.

Via Chartmill

Jazz And Hikma Accused Of Delaying Sleep Disorder Generic Drug To Maintain High Prices ↗

August 28, 2024

Jazz Pharmaceuticals and Hikma Pharmaceuticals will face trial over allegations of delaying a generic version of Xyrem, causing higher drug prices. Plaintiffs accuse Jazz of antitrust violations and...

Via Benzinga

'From Five Minutes Of Agony, It's Now Just Seconds,' Says Brazilian Mother Celebrating Free Access To Her Child's Life-Saving CBD Medicine ↗

August 27, 2024

Via Benzinga

A Closer Look at 12 Analyst Recommendations For Jazz Pharmaceuticals ↗

August 19, 2024

Via Benzinga

Decoding 11 Analyst Evaluations For Jazz Pharmaceuticals ↗

August 01, 2024

Via Benzinga

How Is The Market Feeling About Jazz Pharmaceuticals? ↗

July 15, 2024

Via Benzinga

The Only FDA-Approved CBD Treatment For Severe Epilepsy Completes Key Phase 3 Trial In Japan Despite Missed Primary Goal ↗

August 23, 2024

Via Benzinga

In a market where value is scarce, NASDAQ:JAZZ offers a refreshing opportunity with its solid fundamentals. ↗

August 08, 2024

Don't overlook JAZZ PHARMACEUTICALS PLC (NASDAQ:JAZZ)—it's a hidden gem with strong fundamentals and an attractive price tag.

Via Chartmill

The 3 Best Cannabis Stocks to Buy in August 2024 ↗

August 05, 2024

Although cannabis stocks have been brutalized earlier, favorable legal winds could make the sector intriguing again.

Via InvestorPlace

Topics Cannabis

3 Biotech Stocks to Buy on the Dip: July 2024 ↗

July 29, 2024

Biotech stocks are critically important to the broader market. However, it might make more sense to consider buying on the dip.

Via InvestorPlace

Sage Therapeutics Collapses 21% After Biogen-Tied Essential Tremor Drug Fails ↗

July 24, 2024

The companies are no longer developing their drug for essential tremor treatment.

Via Investor's Business Daily

If You Can Only Buy One Biotech Stock in July, It Better Be One of These 3 Names ↗

July 19, 2024

Evaluating and making money from biotech stocks is incredibly difficult. These three ideas should help your quest if buying in July.

Via InvestorPlace

Assessing Jazz Pharmaceuticals: Insights From 7 Financial Analysts ↗

July 02, 2024

Via Benzinga

Decoding 12 Analyst Evaluations For Jazz Pharmaceuticals ↗

June 05, 2024

Via Benzinga

Is Big Pharma Poised To Take Over Cannabis? 3 Companies Already Manage 8 In 10 Drug Prescriptions In The US ↗

July 11, 2024

The U.S. Federal Trade Commission (FTC) recently highlighted the significant influence of pharmacy benefit managers (PBMs) on drug prices due to market consolidation. This trend raises critical...

Via Benzinga

Topics Cannabis

Avicanna Exports Cannabinoids To Singapore Legally — Even Though Cannabis Is Punishable By Death In The Country ↗

July 11, 2024

Cannabinoid-focused biopharmaceutical company Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) announced on Thursday that through its majority-owned subsidiary Santa Marta Golden Hemp the company...

Via Benzinga

Topics Cannabis

3 Mid-Cap Growth Rockets Trading at Deep Discounts to Their Potential ↗

July 04, 2024

Large cap stocks are where the alpha is now, but there’s a case to be made for these undervalued mid-cap growth stocks

Via InvestorPlace

7 Biotech Stocks to Boost Your Portfolio to Peak Health ↗

June 26, 2024

With biotech stocks commanding a permanently relevant narrative, you can’t afford to ignore these highly endorsed ideas.

Via InvestorPlace

3 Cannabis Stocks That Could Make Your Grandchildren Rich ↗

June 25, 2024

These cannabis stocks offer long-term growth potential anchored by solid operational models and diversified revenue streams today.

Via InvestorPlace

Topics Cannabis

Why Is Jazz Pharmaceuticals Stock Trading Lower On Thursday? ↗

June 20, 2024

Jazz Pharmaceuticals announced Phase 2b trial results for suvecaltamide (JZP385) in essential tremor patients, revealing no significant improvements over placebo.

Via Benzinga

Jazz Dives — And Takes Praxis With It — On Essential Tremor Drug Failure ↗

June 20, 2024

The companies are working on treatments for essential tremor, a tricky indication.

Via Investor's Business Daily

3 Blue-Chip Stocks to Triple Your Wealth by 2026: June Edition ↗

June 14, 2024

These blue-chip stocks offer stability, sustainable growth and operational models less prone to wider economic fluctuations.

Via InvestorPlace

This Old Dominion Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗

June 05, 2024

Via Benzinga

7 Overlooked Stocks Offering Long-Term Stability From the Shadows ↗

June 03, 2024

These overlooked stocks offer price appreciation, income, and more while diversifying across sectors and company sizes.

Via InvestorPlace

3 Cannabis Stocks to Buy Now: May 2024 ↗

May 26, 2024

These cannabis stocks to buy offer the best odds at capturing long-term upside from current rescheduling initiatives.

Via InvestorPlace

Topics Cannabis

7 Blue-Chip Stocks to Buy Now: May 2024 ↗

May 23, 2024

These blue-chip stocks to buy offer long-term price appreciation opportunities reinforced with undeniable stock stability.

Via InvestorPlace

Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch ↗

May 18, 2024

President Joe Biden's administration is moving to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA).

Via Benzinga

Topics Cannabis

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Jazz Pharmaceuticals plc - Ordinary Shares (NQ:JAZZ)

All News about Jazz Pharmaceuticals plc - Ordinary Shares

Starting at /week.